Molecular Partners to Hold Conference Call to Discuss Fourth Quarter and Full Year 2022 Results and Present at the 43rd Annual Cowen Health Care Conference

Rhea-AI Summary

Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech firm specializing in DARPin therapeutics, will release its 2022 financial results on March 9, 2023, followed by an investor call on March 10, 2023. The call will summarize key highlights from Q4 and the full year. CEO Patrick Amstutz is scheduled to present at the 43rd Annual Cowen Health Care Conference on March 8, 2023, in Boston, MA. Investors can access a live webcast of the results presentation on the company’s website, with a replay available for 90 days thereafter.

Positive

• Scheduled release of 2022 financial results indicates ongoing transparency with investors.
• Participation in a major healthcare conference can enhance visibility and attract potential partnerships.

Negative

• None.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, will issue a press release summarizing its highlights and financial results for the fourth quarter and full year of 2022, followed by an investor call the following day. Chief Executive Officer Patrick Amstutz will also deliver a company presentation at the 43^rd Annual Cowen Health Care Conference in Boston, MA. Please see all details below:

Conference Presentation Details:

Cowen Health Care Conference
March 8, 2023, at 9:10am ET (3:10pm CET)
Boston, MA

Full Year 2022 Release Date and Time:

March 9, 2023, 4:00 pm ET (10:00 pm CET)

Call Details:

March 10, 2023, 8:00 am ET (2:00 pm CET)

The full year 2022 results presentation will also be webcast live and will be made available on the Company’s website under the investor section. The replay will be available for 90 days following the presentation.

In order to register for the full year 2022 conference call on March 10, 2pm CET / 8am ET, please dial the following numbers approximately 10 minutes before the start of the presentation:

Switzerland	0800-246787
USA	1-866-652-5200
Full list of dial-in numbers:	Linked here
Conference ID	Please ask to be joined into the Molecular Partners call.

About Molecular Partners AG 
Molecular Partners AG is a clinical-stage biotech company developing DARPin therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics in the areas of oncology and infectious disease and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. www.molecularpartners.com; Find us on Twitter - @MolecularPrtnrs

For further details, please contact:
Seth Lewis
seth.lewis@molecularpartners.com
Tel: +1 781 420 2361

Antonio Ligi, Head of Communications
Zurich-Schlieren, Switzerland
antonio.ligi@molecularpartners.com 
Tel: +41 79 723 36 81

FAQ

When will Molecular Partners release its 2022 financial results?

Molecular Partners will release its 2022 financial results on March 9, 2023, at 4:00 pm ET.

What time is the investor call for Molecular Partners' 2022 results?

The investor call for Molecular Partners' 2022 results is scheduled for March 10, 2023, at 8:00 am ET.

Where is the Cowen Health Care Conference taking place?

The Cowen Health Care Conference will be held in Boston, MA.

What is the focus of Molecular Partners AG?

Molecular Partners AG focuses on developing DARPin therapeutics for oncology and infectious disease.

How can investors access Molecular Partners' 2022 results presentation?

Investors can access the live webcast of the 2022 results presentation on the company’s website.